SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-13-001603
Filing Date
2013-11-15
Accepted
2013-11-15 21:00:35
Documents
1
Period of Report
2013-11-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7169
  Complete submission text file 0001123292-13-001603.txt   9623
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005 3146456600
K-V Pharmaceutical Co (Issuer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SILVER POINT CAPITAL L.P. TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address
MULE EDWARD A (Reporting) CIK: 0001029625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09601 | Film No.: 131225271

Mailing Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830 (203) 542-4000
Silver Point Capital L.P. (Reporting) CIK: 0001332784 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-09601 | Film No.: 131225272

Mailing Address C/O SILVER POINT CAPITAL L.P. TWO GREENWICH PLAZA, FIRST FLOOR GREENWICH CT 06830
Business Address
O'Shea Robert J (Reporting) CIK: 0001382617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09601 | Film No.: 131225270